Concepts (254)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fructose | 10 | 2021 | 62 | 4.860 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 15 | 2025 | 194 | 2.940 |
Why?
|
| Glucose | 12 | 2023 | 871 | 2.390 |
Why?
|
| Lipogenesis | 12 | 2025 | 60 | 2.280 |
Why?
|
| Liver | 13 | 2025 | 1797 | 1.960 |
Why?
|
| Transcription Factors | 10 | 2025 | 2491 | 1.600 |
Why?
|
| Nuclear Proteins | 8 | 2022 | 1285 | 1.490 |
Why?
|
| Insulin | 14 | 2021 | 1168 | 1.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 9 | 2022 | 1418 | 1.070 |
Why?
|
| Insulin Resistance | 11 | 2022 | 698 | 0.960 |
Why?
|
| Lipase | 2 | 2021 | 97 | 0.810 |
Why?
|
| Triglycerides | 4 | 2022 | 617 | 0.800 |
Why?
|
| Succinic Acid | 1 | 2022 | 13 | 0.780 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 4 | 2021 | 420 | 0.740 |
Why?
|
| Systems Analysis | 1 | 2021 | 16 | 0.720 |
Why?
|
| Fibroblast Growth Factors | 3 | 2017 | 165 | 0.720 |
Why?
|
| Hyperinsulinism | 1 | 2021 | 62 | 0.710 |
Why?
|
| Thermogenesis | 2 | 2025 | 51 | 0.700 |
Why?
|
| Homeostasis | 6 | 2023 | 722 | 0.670 |
Why?
|
| Animals | 33 | 2025 | 34850 | 0.670 |
Why?
|
| Hypertriglyceridemia | 1 | 2021 | 114 | 0.660 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 163 | 0.660 |
Why?
|
| Adipose Tissue | 3 | 2014 | 510 | 0.640 |
Why?
|
| Metabolic Diseases | 1 | 2021 | 139 | 0.640 |
Why?
|
| Blood Glucose | 8 | 2025 | 1121 | 0.630 |
Why?
|
| Adipocytes | 4 | 2025 | 182 | 0.630 |
Why?
|
| Fructose Intolerance | 2 | 2017 | 3 | 0.600 |
Why?
|
| Gluconeogenesis | 1 | 2019 | 96 | 0.600 |
Why?
|
| Intestine, Small | 1 | 2021 | 309 | 0.580 |
Why?
|
| Mice | 22 | 2025 | 18507 | 0.580 |
Why?
|
| Obesity | 11 | 2022 | 2398 | 0.580 |
Why?
|
| Insulin-Secreting Cells | 4 | 2022 | 146 | 0.540 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 623 | 0.520 |
Why?
|
| Amino Acids, Branched-Chain | 3 | 2021 | 75 | 0.490 |
Why?
|
| Membrane Proteins | 2 | 2021 | 1597 | 0.480 |
Why?
|
| Lipid Metabolism | 4 | 2025 | 382 | 0.470 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 810 | 0.450 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 365 | 0.430 |
Why?
|
| Energy Metabolism | 4 | 2025 | 784 | 0.420 |
Why?
|
| Mice, Knockout | 8 | 2025 | 3868 | 0.410 |
Why?
|
| Genome-Wide Association Study | 2 | 2019 | 1831 | 0.390 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 797 | 0.390 |
Why?
|
| Signal Transduction | 4 | 2016 | 4720 | 0.340 |
Why?
|
| Fatty Liver | 3 | 2025 | 211 | 0.330 |
Why?
|
| Proteins | 1 | 2015 | 1038 | 0.320 |
Why?
|
| Humans | 36 | 2025 | 132247 | 0.310 |
Why?
|
| Gene Expression Regulation | 5 | 2021 | 2442 | 0.300 |
Why?
|
| Membrane Transport Proteins | 1 | 2010 | 182 | 0.290 |
Why?
|
| Dyslipidemias | 2 | 2022 | 241 | 0.290 |
Why?
|
| Fatty Acids | 2 | 2025 | 356 | 0.280 |
Why?
|
| Acetyl Coenzyme A | 2 | 2025 | 14 | 0.280 |
Why?
|
| Promoter Regions, Genetic | 2 | 2025 | 1284 | 0.250 |
Why?
|
| Glycolysis | 2 | 2016 | 165 | 0.240 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 3 | 2022 | 8 | 0.240 |
Why?
|
| Adipocytes, Brown | 1 | 2025 | 28 | 0.240 |
Why?
|
| Cholesterol, HDL | 3 | 2022 | 398 | 0.230 |
Why?
|
| Adipose Tissue, Brown | 1 | 2025 | 87 | 0.230 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2025 | 2851 | 0.220 |
Why?
|
| Gene Expression Profiling | 2 | 2025 | 1883 | 0.220 |
Why?
|
| Male | 22 | 2025 | 65012 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 7 | 2025 | 4758 | 0.220 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2025 | 124 | 0.220 |
Why?
|
| Lipids | 2 | 2023 | 561 | 0.220 |
Why?
|
| RNA, Messenger | 3 | 2025 | 2680 | 0.210 |
Why?
|
| Glucose Intolerance | 2 | 2016 | 85 | 0.210 |
Why?
|
| Adiposity | 2 | 2018 | 207 | 0.210 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2025 | 291 | 0.210 |
Why?
|
| Glucose Transporter Type 4 | 3 | 2014 | 20 | 0.200 |
Why?
|
| Weight Loss | 4 | 2022 | 515 | 0.200 |
Why?
|
| Succinates | 1 | 2022 | 19 | 0.200 |
Why?
|
| Circadian Rhythm | 1 | 2025 | 316 | 0.200 |
Why?
|
| Citric Acid Cycle | 1 | 2022 | 46 | 0.190 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2022 | 31 | 0.190 |
Why?
|
| Lipoproteins | 2 | 2022 | 187 | 0.190 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 2 | 2021 | 9 | 0.190 |
Why?
|
| Body Weight | 2 | 2019 | 995 | 0.180 |
Why?
|
| Mice, Inbred C3H | 1 | 2021 | 118 | 0.180 |
Why?
|
| Hexoses | 1 | 2021 | 11 | 0.180 |
Why?
|
| Keto Acids | 1 | 2021 | 50 | 0.180 |
Why?
|
| Rodentia | 1 | 2021 | 46 | 0.170 |
Why?
|
| Carbohydrate Metabolism | 1 | 2021 | 51 | 0.170 |
Why?
|
| Dietary Sugars | 1 | 2021 | 16 | 0.170 |
Why?
|
| Metabolomics | 1 | 2025 | 479 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2025 | 861 | 0.170 |
Why?
|
| Cohort Studies | 4 | 2021 | 5176 | 0.170 |
Why?
|
| Female | 19 | 2025 | 70785 | 0.170 |
Why?
|
| Fasting | 3 | 2017 | 302 | 0.170 |
Why?
|
| Fruit and Vegetable Juices | 1 | 2020 | 5 | 0.160 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2020 | 18 | 0.160 |
Why?
|
| Food Deprivation | 1 | 2020 | 34 | 0.160 |
Why?
|
| Bariatric Surgery | 2 | 2019 | 139 | 0.160 |
Why?
|
| Liver Cirrhosis | 2 | 2018 | 898 | 0.160 |
Why?
|
| Haplotypes | 1 | 2021 | 545 | 0.160 |
Why?
|
| Glucagon | 1 | 2020 | 151 | 0.160 |
Why?
|
| Lipoproteins, VLDL | 2 | 2018 | 53 | 0.160 |
Why?
|
| Hepatocytes | 2 | 2022 | 239 | 0.160 |
Why?
|
| Glucosides | 1 | 2020 | 48 | 0.160 |
Why?
|
| Benzhydryl Compounds | 1 | 2020 | 68 | 0.150 |
Why?
|
| Mice, Inbred Strains | 1 | 2019 | 308 | 0.150 |
Why?
|
| Terminology as Topic | 1 | 2021 | 232 | 0.150 |
Why?
|
| Cholesterol | 2 | 2022 | 559 | 0.150 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 386 | 0.150 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2021 | 361 | 0.150 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 2018 | 8 | 0.140 |
Why?
|
| Carboxypeptidases A | 1 | 2018 | 4 | 0.140 |
Why?
|
| Intestines | 1 | 2022 | 606 | 0.140 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2018 | 8 | 0.140 |
Why?
|
| Glucose Transporter Type 5 | 1 | 2017 | 5 | 0.140 |
Why?
|
| Colon | 1 | 2021 | 370 | 0.140 |
Why?
|
| Transcriptome | 1 | 2025 | 1125 | 0.140 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 22 | 0.140 |
Why?
|
| Gastrectomy | 1 | 2019 | 102 | 0.140 |
Why?
|
| Pharmacogenomic Variants | 1 | 2018 | 39 | 0.140 |
Why?
|
| Sugars | 1 | 2018 | 17 | 0.140 |
Why?
|
| Sweetening Agents | 1 | 2017 | 36 | 0.140 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2018 | 118 | 0.130 |
Why?
|
| Beverages | 1 | 2017 | 101 | 0.130 |
Why?
|
| Machine Learning | 1 | 2021 | 348 | 0.130 |
Why?
|
| Mutation, Missense | 1 | 2021 | 937 | 0.130 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2016 | 18 | 0.130 |
Why?
|
| Eye Proteins | 1 | 2018 | 232 | 0.130 |
Why?
|
| Diet | 2 | 2021 | 1125 | 0.130 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2016 | 97 | 0.130 |
Why?
|
| Metformin | 1 | 2018 | 166 | 0.120 |
Why?
|
| Down-Regulation | 1 | 2017 | 679 | 0.120 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2015 | 5 | 0.120 |
Why?
|
| Protein Isoforms | 2 | 2015 | 422 | 0.110 |
Why?
|
| Esters | 1 | 2014 | 35 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2021 | 3358 | 0.110 |
Why?
|
| Risk Assessment | 2 | 2021 | 3736 | 0.110 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 689 | 0.100 |
Why?
|
| Phenotype | 2 | 2021 | 4540 | 0.100 |
Why?
|
| Hyperglycemia | 1 | 2015 | 235 | 0.100 |
Why?
|
| Rats | 4 | 2025 | 3607 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2015 | 881 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 630 | 0.090 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2011 | 98 | 0.090 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 54 | 0.090 |
Why?
|
| Risk Factors | 3 | 2025 | 10945 | 0.090 |
Why?
|
| Vitamin D | 1 | 2012 | 183 | 0.080 |
Why?
|
| Genotype | 2 | 2018 | 2703 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2015 | 3046 | 0.080 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2010 | 50 | 0.080 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2010 | 37 | 0.080 |
Why?
|
| Protein Phosphatase 2C | 2 | 2021 | 60 | 0.080 |
Why?
|
| Adult | 9 | 2025 | 31614 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 3853 | 0.080 |
Why?
|
| Hypertension | 1 | 2018 | 1398 | 0.080 |
Why?
|
| Body Mass Index | 2 | 2012 | 1700 | 0.080 |
Why?
|
| Energy Intake | 1 | 2011 | 493 | 0.070 |
Why?
|
| Middle Aged | 9 | 2021 | 29021 | 0.070 |
Why?
|
| Leptin | 1 | 2010 | 219 | 0.070 |
Why?
|
| Prospective Studies | 4 | 2022 | 6568 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 1381 | 0.070 |
Why?
|
| Cholesterol, LDL | 2 | 2022 | 606 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 3771 | 0.070 |
Why?
|
| Mutation | 1 | 2021 | 6250 | 0.070 |
Why?
|
| Cadaver | 2 | 2018 | 119 | 0.060 |
Why?
|
| Oxygen | 1 | 2010 | 569 | 0.060 |
Why?
|
| Rats, Wistar | 2 | 2018 | 329 | 0.060 |
Why?
|
| Carbon | 1 | 2006 | 94 | 0.060 |
Why?
|
| Biological Transport | 1 | 2006 | 348 | 0.060 |
Why?
|
| Cold Temperature | 1 | 2025 | 83 | 0.060 |
Why?
|
| Coenzyme A | 1 | 2025 | 6 | 0.060 |
Why?
|
| RNA Interference | 2 | 2018 | 515 | 0.060 |
Why?
|
| Models, Biological | 1 | 2010 | 1445 | 0.060 |
Why?
|
| Circadian Clocks | 1 | 2025 | 82 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 4690 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 926 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 3691 | 0.050 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2012 | 846 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 3761 | 0.050 |
Why?
|
| Natriuretic Peptides | 1 | 2022 | 9 | 0.050 |
Why?
|
| Malonyl Coenzyme A | 1 | 2022 | 5 | 0.050 |
Why?
|
| Palmitates | 1 | 2022 | 17 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2022 | 76 | 0.050 |
Why?
|
| Apolipoproteins | 1 | 2022 | 71 | 0.050 |
Why?
|
| Particle Size | 1 | 2022 | 149 | 0.050 |
Why?
|
| Apolipoproteins B | 1 | 2022 | 140 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2025 | 742 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2025 | 1224 | 0.050 |
Why?
|
| Autoantibodies | 1 | 2025 | 458 | 0.050 |
Why?
|
| Feedback | 1 | 2022 | 166 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 275 | 0.040 |
Why?
|
| Meta-Analysis as Topic | 1 | 2021 | 172 | 0.040 |
Why?
|
| Massachusetts | 1 | 2020 | 132 | 0.040 |
Why?
|
| Lipolysis | 1 | 2020 | 75 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2021 | 331 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2018 | 2511 | 0.040 |
Why?
|
| Body Composition | 2 | 2012 | 550 | 0.040 |
Why?
|
| Epinephrine | 1 | 2020 | 155 | 0.040 |
Why?
|
| Rats, Zucker | 1 | 2018 | 24 | 0.040 |
Why?
|
| Organelle Biogenesis | 1 | 2018 | 18 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 206 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2018 | 60 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 68 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2018 | 165 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2018 | 171 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2018 | 133 | 0.030 |
Why?
|
| Mitochondrial Dynamics | 1 | 2018 | 55 | 0.030 |
Why?
|
| Lipoproteins, HDL | 1 | 2018 | 117 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 316 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2019 | 255 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2018 | 304 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 297 | 0.030 |
Why?
|
| Gastric Bypass | 1 | 2017 | 80 | 0.030 |
Why?
|
| Keratin-18 | 1 | 2016 | 8 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 232 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2015 | 54 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2015 | 58 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1500 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 799 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 1050 | 0.030 |
Why?
|
| Adipocytes, White | 1 | 2015 | 27 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 724 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2018 | 761 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 211 | 0.030 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2014 | 74 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2018 | 1653 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 600 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 714 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2015 | 731 | 0.030 |
Why?
|
| Aged | 3 | 2018 | 21482 | 0.030 |
Why?
|
| Adolescent | 2 | 2025 | 20557 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 356 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2015 | 364 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 2451 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1444 | 0.020 |
Why?
|
| Housing, Animal | 1 | 2011 | 17 | 0.020 |
Why?
|
| Incidence | 1 | 2020 | 3376 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 304 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 1350 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2015 | 543 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 94 | 0.020 |
Why?
|
| CHO Cells | 1 | 2011 | 158 | 0.020 |
Why?
|
| Vitamin D Deficiency | 1 | 2012 | 74 | 0.020 |
Why?
|
| Cricetinae | 1 | 2011 | 381 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 377 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 857 | 0.020 |
Why?
|
| Environment | 1 | 2011 | 148 | 0.020 |
Why?
|
| Young Adult | 1 | 2025 | 9966 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3404 | 0.020 |
Why?
|
| Alleles | 1 | 2015 | 1685 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 430 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 6451 | 0.020 |
Why?
|
| Disease Progression | 1 | 2016 | 2233 | 0.020 |
Why?
|
| Registries | 1 | 2016 | 1591 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 3093 | 0.020 |
Why?
|
| Metabolome | 1 | 2010 | 324 | 0.020 |
Why?
|
| Inflammation | 1 | 2014 | 1522 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 7138 | 0.020 |
Why?
|
| Child | 1 | 2025 | 25783 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 13027 | 0.010 |
Why?
|
| United States | 1 | 2016 | 11669 | 0.010 |
Why?
|